BioTech Life Science Medicare 
Health Populi
JULY 11, 2019
This research organization will develop medicines targeting older adults — which makes sense because Clover Health’s target consumer market is Medicare Advantage beneficiaries. The objective of this investment round is to further scale GNS solutions that personalize medicines to individual patients.
Health Populi
MAY 20, 2021
to approve Medicare’s negotiation of drug prices with pharmaceutical companies]. The one segment which has stayed relatively even from 2018 has been biotech, 55% that year and 55% again in 2021. Health Populi’s Hot Points: Two underlying pillars for trust are science-based information and transparency.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Health Populi
MARCH 11, 2021
health care, patient assistance programs, Medicare Advantage plans, and the bundling of proven high-value preventive services into the Affordable Care Act. In the case of Medicare Part D, the drug benefit, Chandra said, “If you’re sick enough to fall into the donut hole, you may have higher mortality.”
Health Populi
JUNE 24, 2021
We also expect innovation to come out of pharma and biotech labs, and who will pay for new-new therapies? For Medicare Part B programs alone, the drug could consume one-half of the total $57 billion of medicines spending… as much as the U.S. spends on NASA.
Health Populi
JUNE 29, 2021
consumers’ bipartisan support for drug price regulation through Medicare negotiation and private/commercial sector adoption. The post Aduhelm and Alzheimer’s Disease: A Potential Medicare Budget-Buster Puts A Blazing Light on Health Care Costs and Innovation appeared first on HealthPopuli.com. and beyond.
Health Populi
JUNE 18, 2020
The authors, Dr. Naci and Dr. Kesselheim, are affiliated with the London School of Economics and Brigham and Women’s Hospital in Boston, note that 1% of medicines dispensed under Medicare Part D and Medicaid accounted for nearly $1 in $3 of drug spending in each program in 2015. bn to $32.8 bn to $9.9 bn for Medicaid.
Digital Health Today
OCTOBER 16, 2019
Like Eko, S-There Technologies and TripleW have devices that allow remote monitoring of patients, presumably capitalizing on the new reimbursement opportunities for Remote Patient Monitoring in the last two Medicare Physician Fee Schedules.
Expert insights. Personalized for you.
228 
Let's personalize your content